Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

national-cancer-institute-9k4fglw6efq-unsplash

NICE recommends treatment combination for advanced leukaemia

April 24, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …
News
mufid-majnun-cm1au42fnrg-unsplash_3

Sanofi offers hepatitis A vaccine for UK children

April 24, 2023 Medical Communications

Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …
News
markus-spiske-hvsr_cvecvi-unsplash

Aptar and Healint announce collaboration on CNS and immune system conditions management

April 24, 2023 Medical Communications

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …
News

RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy

April 21, 2023 Medical Communications

Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …
News

FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay

April 21, 2023 Medical Communications

Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …
News
solen-feyissa-xfnfmlnpwdo-unsplash

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

April 20, 2023 Medical Communications

Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …
News
charles-deloye-2roumsg9rnw-unsplash

Eli Lilly partners with Ivy Tech Community College for scholarship programme

April 20, 2023 Medical Communications

Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …
News
louis-reed-pwckf7l4-no-unsplash_5

ANGLE and BioView partner to develop a CTC-based HER2 assay

April 19, 2023 Medical Communications

ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …
News
mat-napo-qqyix177sy0-unsplash

FDA issues update around changes to COVID-19 vaccines’ EUAs

April 19, 2023 Medical Communications

The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

Neuspera Medical receives FDA approval for peripheral nerve pain system

April 19, 2023 Medical Communications

Medical device company Neuspera Medical has announced that it has received FDA approval for its implantable system, used to treat …
News

GSK enters into £1.6bn deal to acquire Bellus Health

April 18, 2023 Medical Communications

UK-based GSK has announced its plans to acquire Bellus Health, a Canadian late-stage biopharmaceutical company which focuses on treatments for …
News
nik-shuliahin-bunwp1bl0nc-unsplash

FDA approves expanded indication for AbbVie’s chronic migraine treatment

April 18, 2023 Medical Communications

US-based AbbVie has announced that the FDA has granted approval for the expanded indication of its preventative chronic migraine treatment …
News
national-cancer-institute-kluafqlacfw-unsplash

Companies showcase innovative biotech at American Association for Cancer Research

April 17, 2023 Medical Communications

Leading companies in the biotechnology sector will showcase their latest innovations at the American Association for Cancer Research (AACR) meeting …
News

Complement Therapeutics gains €72m in Series A financing for novel therapeutics research

April 17, 2023 Medical Communications

Preclinical stage biotechnology company Complement Therapeutics (CTx) has announced the completion of its Series A financing round, led by Gimv, …
News
hal-gatewood-uo7xjiv4awk-unsplash

Kala Pharmaceuticals receives FDA Fast Track Designation for human MSC-S therapy

April 13, 2023 Medical Communications

Clinical-stage biopharmaceutical company Kala Pharmaceuticals has announced that the FDA has granted it Fast Track Designation for its human mesenchymal …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026